Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
1977-12-29
pubmed:abstractText
During phagocytosis, neutrophils release a variety of substances that include activators and inactivators of chemotactic factors. It is generally considered that these represent hydrolytic enzymes. Elastase and cathepsin G, major proteases released from lysosomal granules during phagocytosis, contain broad hydrolytic activity. This study examined granule elastase and cathepsin G for their role as inactivators of chemotactic factors. Elastase and cathepsin G were purified from human neutrophils by Trasylol-Sepharose and CM-cellulose chromatography. Small amounts (approximately equal to 3 microgram, 1 muM) of elastase and cathepsin G, comparable to quantities released by 10(6) neutrophils during phagocytosis, completely inactivated the C5 chemotactic factor generated in human serum. Larger concentrations were needed to inactivate the C3 chemotactic factor, and when the bacterial chemotactic factor from Escherichia coli was employed, five times more elastase or cathepsin G was ineffective against this chemotactic factor. Supernatant fluid from human neutrophils that had ingested complement-coated zymosan particles contained elastase and cathepsin G and had inactivator activity for both the C5 chemotactic fragment and the bacterial factor. A specific inhibitor of elastase largely abolished the inactivator activity in the phagocytic supernates that was directed against C5 factor but did not affect the inactivator activity for the bacterial factor. Similar results occurred in studies of granule lysates. These data indicate heterogeneity in the chemotactic factor inactivator activity released by phagocytosing neutrophils. The predominant inactivator activity of the C5 chemotactic fragment is attributable to elastase and cathepsin G.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-1082346, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-1184964, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-1203537, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-1247212, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-13273400, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-15426645, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-165239, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-167096, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-181839, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-185683, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-192654, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-239965, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4121701, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4179068, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4201555, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4327465, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4641855, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4737668, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-4985169, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-7245, http://linkedlifedata.com/resource/pubmed/commentcorrection/334799-938478
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1280-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1977
pubmed:articleTitle
Chemotactic factor inactivators of human granulocytes.
pubmed:publicationType
Journal Article